IQVIA HOLDINGS INC. Cost of Revenue
IQVIA HOLDINGS INC. (IQV) reported Cost of Revenue of $912.51 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2013-05-14
- IQVIA HOLDINGS INC. cost of revenue for the quarter ending 2013-03-31 was $912.51M, a 6.22% increase year-over-year.
- IQVIA HOLDINGS INC. cost of revenue for the quarter ending 2012-03-31 was $859.11M.
| Period end | Cost of Revenue 3 month |
|---|---|
| 2013-03-31 | $912.51M 10-Q · filed 2013-05-14 |
| 2012-03-31 | $859.11M 10-Q · filed 2013-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |